Get started
Emmaus Life Sciences, Inc.Emmaus Life Sciences, Inc.Emmaus Life Sciences, Inc.

Emmaus Life Sciences, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsDiscussionsTechnicalsSeasonals

EMMA fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Emmaus Life Sciences, Inc. engages in the discovery, development, marketing, and sale of treatments and therapies for rare and orphan diseases. It operates through the Marketing and Sales of Endari segment. The company was founded on March 20, 1987 and is headquartered in Torrance, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
EMMA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company